The following three stocks are picked by the equity research institution Zacks as the best stocks to buy at the moment by giving Zacks #1 rating (“Buy”).
Read the related article:
Stocks to buy: Zacks #1 Rank Additions for Monday.
Best stock to buy suggested by Zacks: ALNY.
Let’s view their recent financial and stock performance:
Blue Nile, Inc. (NILE) operates as an online retailer of diamonds and fine jewelry. It has three websites serving United States and 16 additional countries and territories globally.
For the second quarter of 2012, Blue Nile recognized revenue of $91.0 million, beating the average analyst estimate of $88.9 million and higher than $80.5 million in the same period of last year. The company posted a net profit of $0.11 per share, topping the average analyst estimate of $0.07 per share and higher than $0.19 per share for the same period of last year. But the gross margin declined 240 basis points from last year same period to 18.9%. Operating margin slipped 270 basis points from a year ago to 2.6%. Net Margin was down 180 basis points to 1.17%. The company forecasts EPS of $0.16 on revenue of $86.7 million for the next quarter; and EPS of $0.68 on revenue of $392.4 million.
NILE stock price jumped more than 34% after the announcement of the second quarter performance last Friday. NILE stock price has a 52-week high of $50.00 and a 52-week low of $22.94. On the basis of the latest closing price of $32.59 on August 7, 2012, which is standing above its 50-day moving average of $28.58 and below its 200-day moving average of $34.2, Blue Nile currently has a market cap of $450.60 million.
According to the data provided by Fact Research, the average rating on the stock is “Buy” and the consensus target of CSU stock price is $15.33, representing a 33.07% upside potential over the current stock price.
Capital Senior Living Corp. (CSU), one of the nation’s largest operators of residential communities for senior adults, together with its subsidiaries, operates 91 senior living communities in the United States.
The senior living communities operator issued its second quarter 2012 results on August 1, 2012. For this quarter, the company generated revenue of $77.0 million, an increase of 19.7%, or $12.7 million from the same period of the prior year. The company grew the Adjusted EBITDAR by 22.8% to $27.7 million, up $5.1 million from the second quarter of 2011. EPS was $0.08, slightly lower than the consensus estimate of $0.09. EBITDAR margin advanced to 36.0% versus 35.1% a year earlier. Same-community occupancies increased 160 basis points from the second quarter of the company has acquired seven communities for an aggregative price of $75.6 million. The company is conducting due diligence on more communities which will bring economic benefit.
CSU stock price has gained 45.09% year to date, and fluctuated between $5.44 and $11.80 over the past 52 weeks; the current stock price of $11.52 is just 2.37% off the one-year high. On the basis of the latest closing price, which is standing above its 50-day moving average of $10.69 and 200-day moving average of $8.99, Capital Senior Living currently has a market cap of $450.60 million.
According to the data provided by Fact Research, the average rating on the stock is “Buy” and the consensus target of CSU stock price is $15.33, representing a 33.07% upside potential over the current stock price.
Cambrex reported the 2012 second quarter financial results on August 1, 2012. Sales added by 4.3%, or 20.2% (excluding the impact of foreign currency) from a year ago. For this quarter, the company grew EBITDA to $19.2 million, up 45.9% from $13.2 million in the same period of last year. Gross margin increased to 36.9% from a year ago of 28.2%. Operating profit advanced to $13.9 million from a year ago of $7.3 million. Net income was $9.93 million or $0.33 per share, 106.25% higher than last year same period’s $4.8 million or $0.16 per share, beating the average analyst estimate. Analysts had previously estimated the company would post EPS of $0.22 per share.
The company expects to grow the full year sales by 10% and 13%, higher than the previously estimated range of 2% to 6%; and realize full year EBITDA of $54 to $58 million, higher than the previously estimated range of $47 and $53 million.
The stock jumped more than 22% on August 2, 2012 after its disclosed its second quarter financial performance. As of now, CBM stock price has advanced 51.11% year to date. CBM stock price was between $4.15 and $11.41 over the past 52 weeks and the current stock price is just 4.91% off the one-year high. On the basis of the latest closing price, which is standing above its 50-day moving average of $8.8 and 200-day moving average of $7.37, Cambrex currently has a market cap of $321.40 million.
The only suggestion is not to jump into a stock just based on a suggestion. To find the best stocks to buy require more hard work. In another word, you need to be aware of how you can carry out basic and technical market analysis to recognise the best stocks to buy at this moment.